ValueQ4, 24TTMSelling/general/admin expenses——Research & development——Operating income-426.69 M-954.33 MNon-Operating Income, Total——Interest expense, net of interest capitalized——Non-Operating Income, excl. Interest Expenses——Unusual income/expense——Pretax income-426.69 M-954.33 MEquity in earnings——Taxes270.97 M715.45 MNon-controlling/minority interest——After tax other income/expense——Net income before discontinued operations-697.66 M-1.67 BDiscontinued operations——Net income-697.66 M-1.67 BDilution adjustment——Preferred dividends——Diluted net income available to common stockholders-697.66 M-1.67 BBasic earnings per share (Basic EPS)——Diluted earnings per share (Diluted EPS)-8.4-20.37Average basic shares outstanding82.48 M313.23 MDiluted shares outstanding83.03 M316.29 MEBITDA——EBIT——Cost of revenue——Other cost of goods sold——Depreciation & amortization (cash flow)350.3 M—
ICON plc
ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.